Home/Filings/4/0001127602-25-008422
4//SEC Filing

Gordon Murdo 4

Accession 0001127602-25-008422

CIK 0000318154other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 7:57 PM ET

Size

4.9 KB

Accession

0001127602-25-008422

Insider Transaction Report

Form 4
Period: 2025-03-03
Gordon Murdo
EVP, Global Commercial Ops
Transactions
  • Award

    Common Stock

    2025-03-03+8,08552,271 total
Footnotes (1)
  • [F1]These shares include 773 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001642156

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 7:57 PM ET
Size
4.9 KB